School of Optometry, Department of Clinical Ophthalmology, Faculty of Health Sciences, Semmelweis University, 17 Vas utca, Budapest 1088, Hungary.
BMC Ophthalmol. 2013 Oct 19;13:58. doi: 10.1186/1471-2415-13-58.
Ingestion of sulphonamide-derived drugs has been reported to possibly have ocular side-effects. Authors aimed to present a rare case of indapamide-induced transient myopia with ciliary body edema and supraciliary effusion.
A 39 years old caucasian female patient presented at the Department of Neurology with headache and sudden bilateral loss of distant vision. Neurological assessment and cranial CT scans were unremarkable. For her hypertension, twice a day bisoprolol 2.5 mg and once a day indapamide 1.5 mg tablets were prescribed several days before. At her presenting, ophthalmic findings were as follows: visual acuity 0.08-7.25Dsph = 1.0 and 0.06-7.25Dsph = 1.0; IOP 25 mmHg and 24 mmHg, anterior chamber depth (ACD) 2.32 mm and 2.49 mm, lens thickness (L) 4.02 mm and 4.09 mm in the right and the left eye, respectively. By means of ultrasound biomicroscopy (UBM), thickened (720 / 700 micron) and detached ciliary body, its forward movement (ciliary body-cornea angle 108' / 114') and forward rotated ciliary processes were seen. Angle opening distance (AOD500) were 300 / 314 microns. By the following days, the myopia gradually diminished, and a week after her first symptoms, her uncorrected visual acuity was 1.0 in both eyes, IOP 13 mmHg and 17 mmHg, ACD 3.68 mm and 3.66 mm, L 3.78 mm and 3.81 mm in the right and the left eye, respectively. Ciliary body edema and detachment disappeared (ciliary body thickness 225 / 230 micron), both of the ciliary body-cornea angle 134' / 140' and the AOD500 (650 / 640 microns) increased. At this point, the patient admitted that she had stopped taking indapamide two days before.
Our case report is the third one in the literature to present indapamide-induced transient myopia, and the first to employ UBM for describing the characteristics of this rare condition. According to the findings, authors suggest that both ciliary muscle contraction and ciliary body edema may play role in the pathomechanism. UBM seems to be a useful tool in the differential diagnosis of acute myopia. Further, authors wish to draw attention to one of the potential adverse effects of this drug which was not listed by its package insert.
已有报道称,摄入磺胺类药物可能会对眼睛产生副作用。作者旨在报告一例吲达帕胺引起的短暂性近视伴睫状体水肿和脉络膜上腔积液的罕见病例。
一名 39 岁的白人女性因头痛和双眼突发性远视力丧失到神经内科就诊。神经评估和头颅 CT 扫描未见异常。她因高血压,每天两次服用比索洛尔 2.5 毫克,每天一次服用吲达帕胺 1.5 毫克,这些药物在她出现症状前几天就开始服用。就诊时,眼科检查结果如下:右眼视力 0.08-7.25Dsph=1.0,左眼视力 0.06-7.25Dsph=1.0;右眼眼压 25mmHg,左眼眼压 24mmHg,前房深度(ACD)右眼 2.32mm,左眼 2.49mm,右眼晶状体厚度(L)4.02mm,左眼晶状体厚度 4.09mm。采用超声生物显微镜(UBM)检查发现,右眼和左眼睫状体均增厚(720 / 700 微米)、脱离,向前运动(睫状体-角膜角 108'/114'),睫状突向前旋转。房角开放距离(AOD500)右眼 300 / 314 微米,左眼 300 / 314 微米。此后几天,近视逐渐减轻,症状出现一周后,右眼和左眼未经矫正的视力分别为 1.0,右眼和左眼眼压分别为 13mmHg 和 17mmHg,右眼和左眼 ACD 分别为 3.68mm 和 3.66mm,右眼和左眼 L 分别为 3.78mm 和 3.81mm。睫状体水肿和脱离消失(睫状体厚度 225 / 230 微米),右眼和左眼睫状体-角膜角均为 134'/140',AOD500 (650 / 640 微米)增加。此时,患者承认她在出现症状前两天已经停止服用吲达帕胺。
本病例报告是文献中第三例吲达帕胺引起的短暂性近视,也是首例采用 UBM 描述这种罕见情况特征的报告。根据这些发现,作者认为睫状肌收缩和睫状体水肿都可能在发病机制中起作用。UBM 似乎是急性近视鉴别诊断的有用工具。此外,作者希望引起人们对这种药物的一种潜在不良反应的关注,而这种不良反应在其说明书中并未列出。